Chimeric Therapeutics: Turning blood cells into cancer seeking “missiles”
Listen to ASX-listed Chimeric Therapeutics Executive Chairman Paul Hopper talk to Matt Birney on the Bulls N’ Bears Report about arguably the most profound development in the fight against cancer to-date – “cell therapy”.